Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

TeleDocs360 vs Vea Health

TeleDocs360
Graded #444

Higher grade

vs+0.20000000000000284
Vea Health
Graded #451

Lower grade

The verdict

TeleDocs360 takes it — 55.2/100 to 55/100, but only just.

TeleDocs360 grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. TeleDocs360 is a cash-pay telehealth service offering compounded GLP-1 weight loss medications, including injectable semaglutide and tirzepatide, oral semaglutide, plus phentermine and NAD+ therapy. Vea Health is close behind and may still be the better fit — see the factor split below.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueVea Health +18
27
45
Dose & formulationTeleDocs360 +24
75
51
Clinical oversightTeleDocs360 +18
84
66
Labs & monitoringEven
52
52
FulfillmentVea Health +8
60
68
Contract termsVea Health +35
20
55
TeleDocs360 · left barVea Health · right bar

The numbers

MetricTeleDocs360Vea Health
WeighScore55.2/10055/100
GradeCC
Scorecard rank#444#451
Semaglutide$399/mo (compounded)Not disclosed
Tirzepatide$399/mo (compounded)Not disclosed
CoverageCoverage not publishedAll 50 states
Brand-name accessCompounded onlyCompounded only
Oral / sublingualYesYes
TeleDocs360

Graded #444 · C

Strengths

  • Transparent $399/month base pricing for standard dosing
  • Multiple GLP-1 options including injectable and oral semaglutide
  • Cash-pay model with HSA/FSA card acceptance
  • Fast online intake and 24-hour prescription approval
  • Cancel anytime between shipments

Where it loses points

  • Compounded-only; no FDA-approved branded options
  • No published state availability list
  • No individual provider credentials or board certifications shown
  • Higher doses increase cost
Vea Health

Graded #451 · C

Strengths

  • Publishes the FDA compounded-medication disclaimer
  • Oral and injection protocols for both semaglutide and tirzepatide
  • Claims 50-state coverage via a clinician network
  • Clearly differentiated positioning (longevity, men's health, performance)

Where it loses points

  • Pricing not shown until after sign-up
  • Pharmacy partner not named (only 'U.S.-based pharmacy')
  • LegitScript certification status not visible
  • No named medical director
  • 503A vs 503B designation not specified

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard